Trademarkia Logo

Canada

C$
Trademark Search in Canada
Seahorse Design

View On IC.GC.CA

Seahorse Design
FORMALIZED

on 28 Jan 2025

TM5 Status

LIVE/APPLICATION/ Under Examination

Your application is under examination.

Last Applicant/ Owned by

RECHERCHES NEURO-HIPPOCAMPE INC. NEURO-HIPPOCAMPUS RESEARCH INC.

100-1600 Carling AveOttawa

ONTARIO

CA

K1Z1G3

Serial Number

2152121 filed on 7th Dec 2021

Correspondent Address

CASSAN MACLEAN IP AGENCY INC.

190 O'CONNOR STREETSUITE 710OTTAWA

ONTARIO

CA

K2P2R3

Seahorse Design

Trademark usage description

promotional items, namely pens promotional items, namely bags promotional items, namely cups and mugs pharmaceutical evaluation services; clinical Read More

Vienna Information

3 . 9 . 14

Sea horsesHippocampes

3 . 9 . 24

Animals of division 3.9 stylizedAnimaux de la division 3.9 stylisés

26 . 1 . 1

CirclesCercles

26 . 1 . 3

One circle or ellipseUn cercle ou une ellipse

26 . 1 . 15

Circles or ellipses containing representations of animals, parts of animals' bodies or plantsCercles ou ellipses contenant la représentation d'animaux, de parties du corps d'un animal ou de végétaux

26 . 1 . 24

Circles or ellipses with dark surfaces or parts of surfacesCercles ou ellipses avec surface ou partie de la surface foncée

Classification Information

Class [016]
Promotional items, namely pens

Classification kind code

11

Class [018]
Promotional items, namely bags

Classification kind code

11

Class [021]
Promotional items, namely cups and mugs

Classification kind code

11

Class [035]
Advertising, marketing, promotional and business

Comment text

CIPO Classification Code

Classification kind code

Nice

Class [041]
Education and entertainment

Comment text

CIPO Classification Code

Classification kind code

Nice

Class [042]
Pharmaceutical evaluation services; clinical trial services, namely the preparation, establishment, running, management and processing of clinical trials and clinical trial data; preclinical services, namely, investigation of biological and chemical material; clinical diagnostic services, namely, diagnosis of conditions, diseases or illnesses; clinical diagnostic services, namely diagnosis of predisposition for conditions, diseases or illnesses, characterizations of disease, response to therapy, patient selection, prognosis and reoccurrence; diagnostic, analytical, testing and monitoring services; clinical research; conducting and analyzing clinical trials in the field of biotechnology, pharmacology, and medical research; medical research in the field of the design and conducting of clinical trials; technical consulting services in the field of clinical trials; training clinical trial site personnel in the field of drug protocol requirements and the use of tests and rating systems for such protocol; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; business management assistance and consultation for clinical trials of investigational drugs, namely, arranging for sites to perform clinical trials, arranging for the import, packaging, shipping, labeling, and distribution of drugs and measuring apparatus, placebo drugs, manuals, precursor and analytical chemicals to and from the clinical trial sites, arranging for the central collection of laboratory specimens from clinical trial sites, preparing statistical reports resulting from clinical trials; medical and healthcare services;

Classification kind code

11

Class [044]
Medical and veterinary, beauty, agricultural and forestry

Comment text

CIPO Classification Code

Classification kind code

Nice

Mark Details

Serial Number

2152121

Mark Type

Trademark

Legal History

Action TakenStatus
Submitted for opposition 22
on 28th Jan 2025		Search Recorded
Submitted for opposition 20
on 28th Jan 2025		Examiner's First Report
Submitted for opposition 48
on 10th Jun 2024		Agent Changed
Submitted for opposition 48
on 29th Mar 2023		Agent Changed
Submitted for opposition 287
on 12th Jul 2022		Pre-Assessment Letter Sent
Submitted for opposition 30
on 7th Dec 2021		Filed
Submitted for opposition 1
on 7th Dec 2021		Created
Submitted for opposition 31
on 7th Dec 2021		Formalized